<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04679051</url>
  </required_header>
  <id_info>
    <org_study_id>19IPLOI34760579</org_study_id>
    <nct_id>NCT04679051</nct_id>
  </id_info>
  <brief_title>Long Sleep Duration and Vascular Function</brief_title>
  <official_title>Effect of Pulsatile Pressure and Long Sleep Duration on Cerebral Vascular Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas Tech University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Heart Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Texas Tech University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sleep duration has received much attention in recent years due to strong evidence that not&#xD;
      enough sleep can increase risk for a number of diseases and disorders. Research is emerging&#xD;
      that too much sleep also has a negative impact on health, particularly higher risk for&#xD;
      myocardial infarction and stroke. The investigators hypothesize that long duration sleep has&#xD;
      the ability to impair peripheral and cerebral vascular function in middle-aged to older&#xD;
      adults.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to compare the effect of long duration sleep (&gt;9 hours) to&#xD;
      recommended levels of sleep (7-8 hours) in a crossover designed study requiring adults to&#xD;
      maintain each prescribed sleep duration for one week. Ambulatory brachial and central aortic&#xD;
      blood pressure will be measured during sleep, while cerebrovascular reactivity, carotid&#xD;
      artery hemodynamics (e.g., flow pulsatility), aortic pulse wave reflections, cognitive&#xD;
      function, and peripheral vasodilatory function will be measured before and after each sleep&#xD;
      protocol. A secondary objective of this study is to understand whether aerobic exercise can&#xD;
      improve vascular function under conditions of different sleep durations. This information&#xD;
      will shed light upon the impact of sleep parameters on exercise-induced improvements in&#xD;
      vascular function.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 16, 2019</start_date>
  <completion_date type="Actual">June 30, 2021</completion_date>
  <primary_completion_date type="Actual">June 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>This project will be a randomized crossover study. Each week will consist of a different time in bed schedule of either 8 or 11 hours time in bed (TIB). The investigators estimated that about 11 hours in bed will result in at least 9 hours of total sleep time (i.e., long duration sleep). Laboratory testing will occur after five consecutive nights of either 8h or 11h TIB to assess the effect of sleep duration on vascular function, and after the sixth consecutive night of TIB to assess the effect of exercise on vascular function under different sleep conditions.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Central aortic blood pressure</measure>
    <time_frame>Change from baseline central blood pressure after exercise</time_frame>
    <description>Central blood pressure (systolic, diastolic, and pulse pressure) measured during sleep using a Oscar2 device</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cerebral vascular reactivity</measure>
    <time_frame>Change from baseline cerebral vascular reactivity after exercise</time_frame>
    <description>Blood flow measured in the middle cerebral artery during hypercapnia using transcranial Doppler and cerebral oxygenation measured during cognitive functioning using near infrared spectroscopy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reactive hyperemia</measure>
    <time_frame>Change from baseline reactive hyperemia after exercise</time_frame>
    <description>Reactive hyperemia in the forearm (ml/100ml/min) measured using venous occlusion plethysmography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Spatial Orientation</measure>
    <time_frame>Change from baseline cognitive throughput after exercise</time_frame>
    <description>Throughput (rate of correct responses per given time) measured during a spatial orientation task (Manikin test)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Executive function</measure>
    <time_frame>Change from baseline executive function after exercise</time_frame>
    <description>Executive function (percent of correct responses) measured during a Stroop color-word test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pressure waveform analysis</measure>
    <time_frame>Change from baseline pressure waveform after exercise</time_frame>
    <description>Forward, reflected, and augmentation pressure assessment using radial artery applanation tonometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mental flexibility</measure>
    <time_frame>Change from baseline mental flexibility after exercise</time_frame>
    <description>Throughput (rate of correct responses per given time) measured during a mental flexibility task (Switching test)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Carotid pulsatility index</measure>
    <time_frame>Change from baseline carotid artery pulsatility after exercise</time_frame>
    <description>Pulsatile behavior of blood flow [(peak systolic/diastolic)/mean flow)] measured using Doppler ultrasound at the common carotid artery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Sleep</condition>
  <arm_group>
    <arm_group_label>8 hours time in bed</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be asked to spend 8 hours time in bed with the aim of achieving one week of normal sleep duration (7 to 8 hours).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>11 hours time in bed</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be asked to spend 11 hours time in bed with the aim of achieving one week of long duration sleep as defined as 9+ hours of sleep.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Sleep duration</intervention_name>
    <description>Participants will be asked to alter time in bed to achieve specified sleep durations.</description>
    <arm_group_label>11 hours time in bed</arm_group_label>
    <arm_group_label>8 hours time in bed</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  recreationally active&#xD;
&#xD;
          -  reporting no recent history of sleep problems&#xD;
&#xD;
          -  not taking sleep-inducing medication&#xD;
&#xD;
          -  not diabetic (fasting blood glucose &lt;126 mg/dL)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  show symptoms of insomnia&#xD;
&#xD;
          -  smoke&#xD;
&#xD;
          -  have a personal history of stroke or diabetes&#xD;
&#xD;
          -  take birth control pills&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joaquin U Gonzales, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Tech University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Texas Tech University</name>
      <address>
        <city>Lubbock</city>
        <state>Texas</state>
        <zip>79409-3011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>December 11, 2020</study_first_submitted>
  <study_first_submitted_qc>December 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 22, 2020</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Texas Tech University</investigator_affiliation>
    <investigator_full_name>Joaquin U Gonzales, PhD</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>sleep duration</keyword>
  <keyword>blood pressure</keyword>
  <keyword>vasodilation</keyword>
  <keyword>cognitive function</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All data collected or generated from the project will be made available on ClinicalTrials.gov within 12 months from the primary completion date</ipd_description>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>All data collected or generated from the project will be made available on ClinicalTrials.gov within 12 months from the primary completion date.</ipd_time_frame>
    <ipd_access_criteria>Open access</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>May 19, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/51/NCT04679051/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

